Market capitalization | $5.87b |
Enterprise Value | $5.46b |
P/E (TTM) P/E ratio | 1,083.54 |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 7.73 |
P/S ratio (TTM) P/S ratio | 8.32 |
P/B ratio (TTM) P/B ratio | 9.20 |
Revenue growth (TTM) Revenue growth | 34.14% |
Revenue (TTM) Revenue | $705.71m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
20 Analysts have issued a Inspire Medical Systems, Inc. forecast:
20 Analysts have issued a Inspire Medical Systems, Inc. forecast:
Jun '24 |
+/-
%
|
||
Revenue | 706 706 |
34%
34%
|
|
Gross Profit | 599 599 |
36%
36%
|
|
EBITDA | -11 -11 |
78%
78%
|
EBIT (Operating Income) EBIT | -14 -14 |
73%
73%
|
Net Profit | 6.01 6.01 |
115%
115%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Head office | United States |
CEO | Timothy Herbert |
Employees | 1,011 |
Founded | 2007 |
Website | www.inspiresleep.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.